Cargando…
Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival
The use of cytoreductive nephrectomy (CRN) in the targeted therapy era is still debated. We aimed to determine factors associated with reduced use of CRN and determine the effect of CRN on overall survival in patients with metastatic renal cell carcinoma (RCC). All advanced RCC diagnosed between 200...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633591/ https://www.ncbi.nlm.nih.gov/pubmed/28834281 http://dx.doi.org/10.1002/cam4.1137 |